FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel
pharmaphorum
DECEMBER 9, 2020
The gist of a briefing document published from FDA reviewers ahead of an expert advisory board meeting is that the vaccine is good to go. Hospitals in the UK have already begun immunising high-risk patients after the country’s regulator became the first in the world to approve the Pfizer/BioNTech vaccine last week. of participants.
111 
Let's personalize your content